KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) EBIT (2016 - 2019)

Historic EBIT for National Health Investors (NHI) over the last 11 years, with Q3 2019 value amounting to $42.8 million.

  • National Health Investors' EBIT rose 433.39% to $42.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $159.4 million, marking a year-over-year increase of 115.25%. This contributed to the annual value of $217.6 million for FY2019, which is 658.66% up from last year.
  • National Health Investors' EBIT amounted to $42.8 million in Q3 2019, which was up 433.39% from $40.0 million recorded in Q2 2019.
  • Over the past 5 years, National Health Investors' EBIT peaked at $46.4 million during Q4 2016, and registered a low of $18.6 million during Q2 2016.
  • In the last 5 years, National Health Investors' EBIT had a median value of $39.2 million in 2018 and averaged $37.8 million.
  • Its EBIT has fluctuated over the past 5 years, first tumbled by 5462.75% in 2016, then skyrocketed by 10613.44% in 2017.
  • Over the past 5 years, National Health Investors' EBIT (Quarter) stood at $42.1 million in 2015, then grew by 10.22% to $46.4 million in 2016, then decreased by 14.64% to $39.6 million in 2017, then rose by 3.52% to $41.0 million in 2018, then rose by 4.33% to $42.8 million in 2019.
  • Its last three reported values are $42.8 million in Q3 2019, $40.0 million for Q2 2019, and $35.7 million during Q1 2019.